Aura Biosciences
Stock Forecast, Prediction & Price Target
Aura Biosciences (AURA) stock Price Target by analysts
$23
Potential upside: 259.37%
Aura Biosciences price prediction

What is Aura Biosciences stock analysts` prediction?
Aura Biosciences stock forecast: Based on 3 Wall Street analysts` predicted price targets for Aura Biosciences in the last 3 months, the avarage price target is $23, with a high forecast of $NaN. The average price target represents a 259.37% change from the last price of $6.4.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Aura Biosciences stock Price Target by analysts
Full breakdown of analysts given Aura Biosciences price targets
Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
---|---|---|---|---|---|---|
Julian Harrison BTIG | 0% 0/1 | 11 months ago | $24 275% upside | $10.29 | StreetInsider | Previous targets (0) |
George Farmer Scotiabank | 0% 0/1 | 11 months ago | $23 259.37% upside | $10.29 | StreetInsider | Previous targets (0) |
Ed White II H.C. Wainwright | 0% 0/1 | 11 months ago | $22 243.75% upside | $10.29 | StreetInsider | Previous targets (0) |
Edward White H.C. Wainwright | 0% 0/1 | about 1 year ago | $21 228.12% upside | $9.27 | TheFly | Previous targets (0) |
Unknown JMP Securities | N/A | almost 3 years ago | $30 368.75% upside | $12.95 | Benzinga | N/A |
Aura Biosciences Financial Estimates
Aura Biosciences Revenue Estimates
Aura Biosciences EBITDA Estimates
Aura Biosciences Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $18.7M Low: $18.7M High: $18.7M avg. 0% | Avg: $19.2M Low: $19.2M High: $19.2M avg. 2.67% | Avg: $17.5M Low: $17.5M High: $17.5M avg. -8.85% | Avg: $109.2M Low: $109.2M High: $109.2M avg. 524% |
Net Income
% change YoY
| $-34.42M N/A | $-57.23M -66.26% | $-76.40M -33.50% | Avg: $-108.51M Low: $-90.72M High: $-65.37M avg. -42.01% | Avg: $-133.8M Low: $-97.86M High: $-71.31M avg. -23.30% | Avg: $-101.31M Low: $-101.31M High: $-101.31M avg. 24.27% | Avg: $-66.56M Low: $-66.56M High: $-66.56M avg. 34.30% |
EBITDA
% change YoY
| $-35.23M N/A | $-59.96M -70.18% | $-83.69M -39.56% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.18 N/A | -$1.91 -61.86% | -$1.93 -1.04% | Avg: -$1.98 Low: -$2.29 High: -$1.65 avg. -2.59% | Avg: -$2.15 Low: -$2.47 High: -$1.8 avg. -8.41% | Avg: -$2.56 Low: -$2.56 High: -$2.56 avg. -19.12% | Avg: -$1.68 Low: -$1.68 High: -$1.68 avg. 34.30% |
Operating Expenses
% change YoY
| $35.25M N/A | $60.29M 71.04% | $84.99M 40.95% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Aura Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -1.68% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -90.72M, average is -108.51M and high is -65.37M.
What is Aura Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 129.45% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $18.7M, average is $18.7M and high is $18.7M.
What is Aura Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 1.04% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$2.29, average is -$1.98 and high is $-1.65.
What is the best performing analyst?
In the last twelve months 3 analysts have been covering Aura Biosciences stock. The most successful analyst is Julian Harrison.